Syros Pharmaceuticals: Rising Despite Dilution, A Must Look (NASDAQ:SYRS)

[ad_1]

3d illustration of the strong increase of non-functional white blood cells called leukemia cells leading to blood cancer disease

Christoph Burgstedt/iStock via Getty Images

Topline Summary

Syros Pharmaceuticals (NASDAQ:SYRS) is a cancer-focused developmental biotech working on novel therapies for different forms of blood cancer. They currently have one main drug in development, for which they have encouraging data and

[ad_2]

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *